Product Reports Resources Pricing Login Book a demo

Sea Hunter Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2018

Vertically integrated pharmaceutical and consumer packaged goods company MoreLess

Sea Hunter Therapeutics operates in the burgeoning cannabis industry, offering a comprehensive suite of services and products designed to support the growth and success of cannabis brands worldwide. The company serves a diverse range of clients, including dispensaries, cultivators, and cannabis product manufacturers. Operating primarily in North America, Sea Hunter Therapeutics leverages a portfolio of specialized companies to deliver end-to-end solutions. These include Baker, a leading CRM platform for dispensaries; Jupiter Research, known for its award-winning vaporizer technology; and Commonwealth Alternative Care, which provides medical cannabis products. The business model is vertically integrated, encompassing cultivation, production, distribution, and retail. Revenue is generated through the sale of cannabis products, technology solutions, and consulting services. The company is well-positioned in a newly regulated market, focusing on innovation and long-term success.

Keywords: cannabis, CRM, vaporizer, medical cannabis, cultivation, distribution, dispensaries, technology, innovation, patient care.

Company overview

Sea Hunter Therapeutics company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2018
Headquarters
Cambridge, United States
Employees
1
Open positions
None listed
Dealroom signal
25.3
Investment activity
3 companies · latest Nov 2018
Capital deployed
Preferred round
MERGER
sub industryPharmaceuticalsectorConsumer Goodsbusiness modelManufacturingsectorWholesalesectorIntellectual PropertyindustryHealthsectorRetailsectorBiotechnologysectorCannabissectorBiotech and PharmasectorHard TechsectorDT and LSsectorscience-basedclient focusb2b

Valuation & funding

Sea Hunter Therapeutics funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
MERGEROther financing Nov 2018 $0 Baker Technologies · Briteside · Sante Veritas Therapeutics
GROWTH EQUITY VCOther financing Jul 2018 $76M $534M Undisclosed
Showing 2 recorded eventsUnlock the complete deal history →

Growth signals

Sea Hunter Therapeutics website traffic

Latest recorded traffic for Sea Hunter Therapeutics is 230 monthly website visits. Sea Hunter Therapeutics's team grew 0% over the past year.

Latest monthly visits230 1-year team growth0%
Monthly website visits31 observations · Nov 2017–Sep 2022
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Sea Hunter Therapeutics compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Sea Hunter Therapeutics's talent

Book a demo to see the people
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

3 investors on Sea Hunter Therapeutics's cap table

Sourced from Dealroom's funding and investor records.

Other known 3 additional known investors
Baker Technologies
Briteside
Sante Veritas Therapeutics

Global footprint

Where Sea Hunter Therapeutics has talent and traffic

Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown

In the news

Latest news about Sea Hunter Therapeutics

Recent press, funding announcements, and product moves mentioning Sea Hunter Therapeutics — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Sea Hunter Therapeutics

An AI-synthesized read of the highest-engagement posts about Sea Hunter Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sea Hunter Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.